Iloprost Nebulization Dose
For pulmonary arterial hypertension, start inhaled iloprost at 2.5 μg per dose; if well-tolerated, increase to 5 μg per dose, administered 6-9 times daily (not more than once every 2 hours while awake), with a maximum daily dose of 45 μg. 1
Dosing Algorithm
Initial Dosing
- Starting dose: 2.5 μg inhaled
- Titration: If the initial 2.5 μg dose is well-tolerated, increase subsequent doses to 5 μg
- Frequency: 6-9 inhalations per day
- Timing: Not more than once every 2 hours while awake (with a night pause)
- Maximum daily dose: 45 μg per day 1
Maintenance Dosing
- Target dose: 2.5-5 μg per inhalation
- Typical regimen: Most patients use 5 μg per dose, 6-9 times daily
- Median effective dose: 30 μg/day (based on clinical trial data) 2
Administration Details
Nebulization Time
- Jet nebulizers: Approximately 10-15 minutes per inhalation 3, 2
- Ultrasound nebulizers: Can reduce inhalation time to approximately 5 minutes 2
- Modern mesh nebulizers (BREELIB®): Significantly reduced inhalation time while maintaining tolerability 4
Practical Considerations
The frequent dosing requirement (6-9 times daily) is necessary due to iloprost's short half-life of 20-25 minutes 2. Each inhalation session taking 10-15 minutes means patients spend 60-135 minutes daily on treatment, which can impact compliance 2.
Pediatric Dosing
In pediatric patients, dosing has not been fully established, but guidelines suggest starting with 2.5 μg and uptitrating to 5 μg as tolerated, with 6-9 inhalations per day required. 3 The dosing frequency may limit usefulness in younger children who cannot perform controlled inhalation maneuvers.
Alternative Routes (for context)
While the question focuses on nebulization, iloprost can also be administered:
- Intravenous: 0.5-2.0 ng/kg/min infusion over 6 hours daily 1
- This route is used when inhaled therapy is not feasible or for more severe disease
Common Pitfalls to Avoid
- Inadequate dose escalation: Starting at 2.5 μg is appropriate, but failing to increase to 5 μg when tolerated may result in suboptimal efficacy
- Insufficient frequency: Using fewer than 6 inhalations daily reduces sustained clinical benefit due to the drug's short half-life 2
- Exceeding maximum daily dose: Do not exceed 45 μg total daily dose 1
- Dosing intervals too close: Maintain at least 2-hour intervals between doses while awake 1
Tolerability Profile
Most common side effects are mild and transient: cough, flushing, headache, and jaw pain 2. These typically do not require discontinuation. If side effects are problematic at 5 μg, patients can remain on 2.5 μg per dose 3. Systemic hypotension is rare with inhaled administration 2, 5.
Evidence Quality
The dosing recommendations are consistent across multiple high-quality guidelines from 2004-2023, including the 2023 Nature Reviews Rheumatology guidelines 1, 2015/2016 ESC/ERS guidelines 6, and 2019 CHEST guidelines 7. The pivotal AIR trial established the 2.5-5 μg dose range with 6-9 daily inhalations as the evidence-based standard 2.